Unexpected Low Expression of Platelet Fibrinogen Receptor in Patients With Chronic Myeloproliferative Neoplasms: How Does It Change With Aspirin?

British Journal of Haematology - United Kingdom
doi 10.1111/bjh.16335
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Wiley

Related search

JAK2 Exon 14 Deletion in Patients With Chronic Myeloproliferative Neoplasms

PLoS ONE
Multidisciplinary
2010English

Lymphoproliferative Disorders in Patients With Chronic Myeloproliferative Neoplasms: A Systematic Review

American Journal of Hematology
Hematology
2018English

Epigenetics and Mutations in Chronic Myeloproliferative Neoplasms

Haematologica
Hematology
2011English

Circulating Endothelial Cells in Patients With Venous Thromboembolism and Myeloproliferative Neoplasms

PLoS ONE
Multidisciplinary
2013English

Survival of Patients With Chronic Myeloproliferative Neoplasms and New Primary Cancers: A Population-Based Cohort Study

The Lancet Haematology
Hematology
2015English

JAK2, CALR, and MPL Mutation Spectrum in Japanese Patients With Myeloproliferative Neoplasms

Haematologica
Hematology
2014English

High Concordance in Grading Reticulin Fibrosis and Cellularity in Patients With Myeloproliferative Neoplasms

Modern Pathology
Forensic MedicinePathology
2014English

Diagnostic and Prognostic Contribution of Targeted NGS in Patients With Triple‐negative Myeloproliferative Neoplasms

American Journal of Hematology
Hematology
2019English

Anticoagulation in Elderly Patients With Chronic Kidney Disease: How Safe Is It?

Canadian Journal of Cardiology
Cardiovascular MedicineCardiology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy